ArticleThe journal of vascular access2026
Hemodialysis catheter-related bacteremia rate is reduced by the use of 0.1% polyhexanide-betaine in a pediatric unit.
Article in The journal of vascular access, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Methods for skin load reduction of Candida auris: a systematic review.Antimicrobial resistance and infection control · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInfection is one of the main catheter-related complications in children undergoing hemodialysis. Polyhexanide-betaine (PHMB-B) is a broad-spectrum biocide that is especially useful for removing biofilms and improving wound healing. However, there is no evidence regarding its use in routine hemodialysis exit-site care.
methodsIn January 2019, we implemented a new exit site care protocol using PHMB-B over 2% chlorhexidine. The aim of our study was to evaluate the effect of this new protocol on catheter-related bacteremia (CRB) and exit-site infection (ESI) rates. For this, we conducted a retrospective chart analysis of pediatric patients admitted to our hemodialysis unit with tunneled catheters from January 2017 to December 2020, comparing incidence rates before and after protocol implementation. CRB was defined as the presence of infectious symptoms without apparent sources, with defervescence after antibiotic treatment and/or catheter removal, with or without microbiological confirmation. ESI was defined as the presence of purulent discharge with/without skin erythema ⩽2 cm from the exit site.
resultsTwenty children (50% female) aged 4 months-15 years old were admitted to our unit, for a total of 6177 catheter days. After the implementation of our new protocol, the CRB event rate decreased from 2.64 (10 events) to 0.41/1000 catheter-days (1 event;
conclusionsThe use of PHMB-B in routine catheter exit site care could be useful in the prevention of catheter-related infectious complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.